• 1
    Sharp JT. Radiologic assessment as an outcome measure in rheumatoid arthritis. Arthritis Rheum 1989; 32: 2219.
  • 2
    Genant HK, Jiang Y, Peterfy C, Lu Y, Rédei J, Countryman PJ. Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs. Arthritis Rheum 1998; 41: 158390.
  • 3
    Sharp JT, Lidsky MD, Collins LS, Moreland J. Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971; 14: 70620.
  • 4
    Genant HK. Methods of assessing radiographic change in rheumatoid arthritis. Am J Med 1983; 75: 3547.
  • 5
    Fries JF, Bloch DA, Sharp JT, McShane DJ, Spitz P, Bluhm GB, et al. Assessment of radiologic progression in rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 1986; 29: 19.
  • 6
    Larsen A, Thoen J. Hand radiography of 200 patients with rheumatoid arthritis repeated after an interval of one year. Scand J Rheumatol 1987; 16: 395401.
  • 7
    Fuchs HA, Kaye JJ, Callahan LF, Nance EP, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989; 16: 58591.
  • 8
    Pincus T, Callahan LF, Fuchs HA, Larsen A, Kaye J. Quantitative analysis of hand radiographs in rheumatoid arthritis: time course of radiographic changes, relation to joint examination measures, and comparison of different scoring methods. J Rheumatol 1995; 22: 19839.
  • 9
    Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949; 140: 65962.
  • 10
    Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagn 1977; 8: 48191.
  • 11
    Sharp JT, Young DY, Bluhm GB, Brook A, Brower AC, Corbett M, et al. How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum 1985; 28: 132635.
  • 12
    Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum 1995; 38: 15160.
  • 13
    Van de Loo FAJ, Joosten LAB, van Lent PLEM, Arntz OJ, van den Berg WB. Role of interleukin-1, tumor necrosis factor α, and interleukin-6 in cartilage, proteoglycan metabolism and destruction: effect of in situ blocking of murine antigen- and zymosan-induced arthritis. Arthritis Rheum 1995; 38: 16472.
  • 14
    Eastgate JA, Symons JA, Wood NC, Grinlinton FM, di Giovine FS, Duff GW. Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 1988; 2: 7069.
  • 15
    Kahle P, Saal JG, Schaudt K, Zacher J, Fritz P, Pawele G. Determination of cytokines in synovial fluids: correlation with diagnosis and histomorphological characteristics of synovial tissue. Ann Rheum Dis 1992; 51: 7314.
  • 16
    Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095147.
  • 17
    Van Lent PLEM, van de Loo FAJ, Holthuysen AEM, van den Bersselaar LAM, Vermeer H, van den Berg WB. Major role for interleukin 1 but not tumor necrosis factor in early cartilage damage in immune complex arthritis in mice. J Rheumatol 1995; 22: 22508.
  • 18
    Hutchinson NI, Lark MW, MacNaul KL, Harper C, Hoerrner LA, McDonnell J, et al. In vivo expression of stromelysin in synovium and cartilage of rabbits injected intraarticularly with interleukin-1β. Arthritis Rheum 1992; 35: 122733.
  • 19
    Arend WP, Welgus HG, Thompson RC, Eisenberg SP. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990; 85: 16947.
  • 20
    Pelletier J-P, Caron JP, Evans C, Robbins PD, Georgescu HI, Jovanovic D, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997; 40: 10129.
  • 21
    Bakker AC, Joosten LAB, Arntz OJ, Helsen MMA, Bendele AM, van de Loo FAJ, et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 1997; 40: 893900.
  • 22
    Chole RA, Faddis BT, Tinling SP. In vivo inhibition of localized bone resorption by human recombinant interleukin-1 receptor antagonist. J Bone Miner Res 1995; 10: 2814.
  • 23
    Kimble RS, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung VT, et al. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 1994; 93: 195967.
  • 24
    Campion GV, Lesback ME, Lookabaugh J, Gordon G, Catalano M, and the IL-1Ra Arthritis Study Group. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1996; 39: 1092101.
  • 25
    Bresnihan B, Alvaro-Gracia JM, Cobby M, Doherty M, Domljan Z, Emery P. Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum 1998; 41: 2196204.
  • 26
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 27
    Genant HK, Kirby DS, Pickering EA, Loose LD, Weiner ES, Ting N. Tenidap slows x-ray deterioration in rheumatoid arthritis [abstract]. Arthritis Rheum 1995; 38 Suppl 9: S330.
  • 28
    Genant HK, Rédei J, Ouyang X, Countryman PJ. CD-ROM-based high-resolution digital image workstation for multicenter rheumatoid arthritis drug trials. Zurich: EULAR; 1997.
  • 29
    Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 72735.
  • 30
    Geusens P, Wouters C, Nijs J, Jiang Y, Dequeker J. Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis: a 12-month, double-blind, controlled study. Arthritis Rheum 1994; 37: 8249.
  • 31
    Peterfy CG, Dion E, Miax Y, White DL, Jiang Y, Genant HK. MRI is twice as sensitive as radiography for monitoring progression of bone erosion in rheumatoid arthritis [abstract]. Radiology 1998; 209: 500.
  • 32
    Sharp JT, Bluhm GB, Brook A, Brower AC, Corbett M, Decker JL, et al. Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthritis Rheum 1985; 28: 1624.
  • 33
    Jiang Y, Peterfy C, Lu Y, Redei J, Countryman P, Genant HK. Semiquantitative scoring of high-resolution laser-digitized images versus original conventional radiographs in patients with rheumatoid arthritis [abstract]. Radiology 1998; 206: 857.
  • 34
    Weinblatt ME, Polisson R, Blotner SD, Sosman JL, Aliabadi P, Baker N, et al. The effects of drug therapy on radiographic progression of rheumatoid arthritis: results of a 36-week randomized trial comparing methotrexate and auranofin. Arthritis Rheum 1993; 36: 6139.
  • 35
    Pincus T. Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trial. J Clin Epidemiol 1988; 41: 103741.
  • 36
    Multicentre Trial Group. Controlled trial of D-penicillamine in severe rheumatoid arthritis. Lancet 1973; 1: 27580.
  • 37
    Borg G, Allander E, Berg E. Auranofin treatment in early rheumatoid arthritis may postpone early retirement: results from a 2-year double blind trial. J Rheumatol 1991; 18: 101520.
  • 38
    Scott DL, Grindulis KA, Struthers GR, Coulton BL, Popert AJ, Bacon PA. Progression of radiologic changes in rheumatoid arthritis. Ann Rheum Dis 1984; 43: 817.
  • 39
    Paulus HE, Egger MJ, Ward JR, Williams HJ, and the Cooperative Systematic Studies of Rheumatic Diseases Group. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 1990; 33: 47784.
  • 40
    Van der Heijde DMFM, van Leeuwen MA, van Riel PLCM, Koster AM, van 't Hof MA, van Rijswijk MH, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992; 35: 2634.
  • 41
    Sharp JT. Radiographic evaluation of the course of articular disease. Clin Rheum Dis 1983; 9: 54157.